• <th id="oxmkd"></th>
  • <source id="oxmkd"><li id="oxmkd"></li></source>
    <code id="oxmkd"><menu id="oxmkd"></menu></code>
  • <mark id="oxmkd"></mark>
  • <th id="oxmkd"><td id="oxmkd"></td></th>

    <pre id="oxmkd"><em id="oxmkd"><track id="oxmkd"></track></em></pre>

    Pharmaceutical Manufacturing Industry Profile

    Report Page Length: 10-12
    Last Quarterly Update: 3/29/2021
    SIC Codes: 283
    NAICS Codes: 3254
    Chapters Include:
    Industry Overview Trends & Challenges Industry Forecast
    Quarterly Industry Update Call Prep Questions Website & Media Links
    Business Challenges Financial Information Glossary & Acronyms
    View Full Sample Add To Cart

    Excerpt from Pharmaceutical Manufacturing Industry Profile

    Companies in this industry manufacture and process pharmaceutical products. Major companies include Bristol Myers Squibb, Eli Lilly, Johnson & Johnson, Merck & Co, and Pfizer (all based in the US), as well as AstraZeneca (UK), Bayer (Germany), GlaxoSmithKline (UK), Novartis (Switzerland), Roche Holding (Switzerland), and Sanofi (France).

    Annual worldwide revenue from pharmaceutical manufacturing is about $1 trillion and is expected to reach $1.1 trillion by 2024, according to a 2020 forecast from market intelligence firm IQVIA. Worldwide spending on medicines is increasing due to economic growth in developing nations and the rising cost of specialty drugs. The US, the EU, and Switzerland remain the largest importers of pharmaceuticals, but manufacturers are targeting emerging economies for growth.

    The US pharmaceutical manufacturing industry includes about 2,400 establishments (single-location companies and units of multi-location companies) with combined annual revenue of about $210 billion.

    COMPETITIVE LANDSCAPE

    Pharmaceutical manufacturers compete to discover and commercialize ever-more effective medicines. Companies focus on the most profitable markets, where demand for treatment is high. Key areas of development include cardiovascular, cancer, and diabetes medications, as increases in the number of elderly and obese patients fuel disease growth in these categories. Companies may also focus on rare disease categories, where available treatments are limited or nonexistent and opportunities exist for expedited approvals and profitable pricing.

    The traditional drug manufacturing industry increasingly overlaps with the biotechnology industry, which is a source of many new ...

     
    View Full Sample Add To Cart Return to the Industry Profile Menu
    Add To Cart

    Focus Profiles

    Complement this Industry Profile by purchasing a Focus Profile. Pharmaceutical Manufacturing has one Focus Profiles that can help you better understand this industry:

    Would you or your company benefit from having unlimited access to First Research's industry intelligence tools?

    Learn More About Subscription Options
     
    www,小明,com/_视频二区 亚洲 欧美_大香蕉伊人综合在线33